
Join to view full profile
8700 Beverly BlvdWest Hollywood, CA 90048
Phone+1 310-967-1884
Fax+1 310-967-8739
Dr. Hu is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 2005 - 2008
Santa Clara Valley HealthcareResidency, Internal Medicine, 2004 - 2005
University of California San Francisco School of MedicineClass of 2004
Certifications & Licensure
CA State Medical License 2006 - 2028
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
- Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
- Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma Start of enrollment: 2014 Jan 08
- Ketogenic Diet in Combination With Standard-of-care Radiation and Temozolomide for Patients With Glioblastoma Start of enrollment: 2018 Apr 13
Publications & Presentations
PubMed
- Nutrition and Its Impact on Quality of Life in Patients with Brain Tumors: A Scoping Review.Jude Banihani, Stephanie Cramer, Jethro Hu
Cancers. 2026-01-27 - 8 citationsA phase 1 safety and feasibility trial of a ketogenic diet plus standard of care for patients with recently diagnosed glioblastoma.L J Amaral, Gillian Gresham, Sungjin Kim, Mourad Tighiouart, Thomas A Nelson
Scientific Reports. 2025-07-01 - 26 citationsClinical research framework proposal for ketogenic metabolic therapy in glioblastoma.Tomás Duraj, Miriam Kalamian, Giulio Zuccoli, Joseph C Maroon, Dominic P D'Agostino
BMC Medicine. 2024-12-05
Journal Articles
- Myxoid Glioneuronal Tumor of the Septum Pellucidum and Lateral Ventricle Is Defined by a Recurrent PDGFRA p.K385 Mutation and DNT-like Methylation ProfileMelike Pekmezci, Andrew W Bollen, David A Solomon, Xuemo Fan, Serguei Bannykh, James Johnston, Elaine Cham, James P Grenert, Boris C Bastian, Arie Perry, Moise Danielp..., Acta Neuropathologica
Press Mentions
Researchers Look To Fasting as a Next Step in Cancer TreatmentJanuary 10th, 2024
Grant Support
- A randomized controlled phase 2 study of the ketogenic diet for patients with newly diagnosed glioblastoma in combination with standard-of-care treatmentCEDARS-SINAI MEDICAL CENTER2023–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









